胰腺肿块的次谐波与内镜超声造影成像:一项先导研究
本先导研究纳入16例拟行胰腺肿块活检的患者,比较次谐波成像(SHI)与超声内镜造影(EUS)显示肿瘤血流的能力。SHI在肿块内的造影-组织比显著高于EUS,但两者诊断准确率均低(<53%),SHI的读片者间一致性κ值高于EUS。
要点
- SHI可清晰显示胰腺肿块内血流,肿块内造影-组织比显著高于EUS。
- SHI与EUS诊断准确率均低(<53%),但SHI读片者间一致性κ值高于EUS。
- 两组在周围血管的造影-组织比及按病理结果分组比较均无差异。
核心结论
- 本先导研究中,超声内镜造影与经腹次谐波成像评估胰腺肿块的诊断准确率均很低,但SHI的肿瘤造影-组织比优于EUS。
研究设计与样本
- 经机构审查委员会批准的先导研究,共纳入16例拟行胰腺肿块活检的患者。
- SHI采用LOGIQ 9系统(GE Healthcare,Milwaukee,WI)与4C探头,脉冲反相方式发射/接收频率为2.5/1.25 MHz。
- 超声内镜造影采用径向内镜(GF-UTC180;Olympus Corporation,东京,日本)连接ProSound SSD α-10扫描仪(Hitachi Aloka,东京,日本),谐波造影发射/接收频率为4.7/9.4 MHz。
- 造影剂Definity(Lantheus Medical Imaging,North Billerica,MA)注射两次,EUS与SHI剂量分别为0.3-0.4 mL与0.6-0.8 mL。
- 以病理结果为参考,由4名医师独立对图像进行良性至恶性评分,评估诊断准确率与读片者间一致性。
关键影像表现/征象
- 所有患者均获得明显的次谐波信号,SHI可清晰显示肿瘤内血流。
诊断标准与关键数值
- 肿块内造影-组织比:SHI为1.71 ± 1.63,EUS为0.63 ± 0.89,SHI显著高于EUS(P = .016)。
- 周围血管的造影-组织比及按病理结果分组比较均无差异(P > .60)。
- 造影EUS与SHI的诊断准确率均低(<53%)。
- 读片者间一致性κ值:SHI为0.34,EUS为0.13。
临床应用与阅片要点
- SHI可作为经腹超声评估胰腺肿块血流的补充手段,但本先导研究中其诊断准确率低,读片者间一致性κ值仅为0.34。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To use subharmonic imaging (SHI) to depict the vascularity of pancreatic masses compared to contrast-enhanced endoscopic ultrasound (EUS) and pathologic results.
METHODS: Sixteen patients scheduled for biopsy of a pancreatic mass were enrolled in an Institutional Review Board-approved study. Pulse-inversion SHI (transmitting/receiving at 2.5/1.25 MHz) was performed on a LOGIQ 9 system (GE Healthcare, Milwaukee, WI) with a 4C transducer, whereas contrast harmonic EUS (transmitting/receiving at 4.7/9.4 MHz) was performed with a radial endoscope (GF-UTC180; Olympus Corporation, Tokyo, Japan) connected to a ProSound SSD α-10 scanner (Hitachi Aloka, Tokyo, Japan). Two injections of the contrast agent Definity (Lantheus Medical Imaging, North Billerica, MA) were administrated (0.3-0.4 and 0.6-0.8 mL for EUS and SHI, respectively). Contrast-to-tissue ratios (CTRs) in the mass and an adjacent vessel were calculated. Four physicians independently scored the images (benign to malignant) for diagnostic accuracy and inter-reader agreement.
RESULTS: One patient dropped out before imaging, leaving 11 adenocarcinomas, 1 gastrointestinal stromal tumor with pancreatic infiltration, and 3 benign masses. Marked subharmonic signals were obtained in all patients, with intratumoral blood flow clearly visualized with SHI. Significantly greater CTRs were obtained in the masses with SHI than with EUS (mean ± SD, 1.71 ± 1.63 versus 0.63 ± 0.89; P = .016). There were no differences in the CTR in the surrounding vessels or when grouped by pathologic results (P > .60). The accuracies for contrast EUS and SHI were low (<53%), albeit with a greater κ value for SHI (0.34) than for EUS (0.13).
CONCLUSIONS: Diagnostic accuracy of contrast EUS and transabdominal SHI for assessment of pancreatic masses was quite low in this pilot study. However, SHI had improved tumoral CTRs relative to contrast EUS.
引用
- Forsberg F, Stanczak M, Lyshchik A, et al. Subharmonic and Endoscopic Contrast Imaging of Pancreatic Masses: A Pilot Study. J Ultrasound Med. 2017. PMID: 28681437. doi:10.1002/jum.14310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。